SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-22-008764
Filing Date
2022-03-04
Accepted
2022-03-04 16:15:28
Documents
5
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A evok-pre14a_20220427.htm PRE 14A 1098811
2 GRAPHIC gggkwi4e2hev000002.jpg GRAPHIC 17621
3 GRAPHIC gggkwi4e2hev000001.jpg GRAPHIC 17621
4 GRAPHIC gggkwi4e2hev000004.jpg GRAPHIC 72812
5 GRAPHIC gggkwi4e2hev000003.jpg GRAPHIC 135464
  Complete submission text file 0001564590-22-008764.txt   1435771
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36075 | Film No.: 22714237
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences